How will superintelligent artificial intelligence transform biological research and drug discovery?

The traditional biopharmaceutical pipeline is constrained by human cognitive bandwidth and sequential trial-and-error experimentation. Frontier models will compress fifty years of scientific discovery into five, predicting complex protein dynamics, simulating cellular disease pathways, and designing targeted therapies for intractable cancers. It will spark a golden age of human health and longevity.